WNT5A was shown to promote prostate cancer cell dormancy in bone.5 Thus, the researchers hypothesized that sFRP1 may reactivate dormant melanoma cells and resume proliferation by inhibiting WNT5A signaling. This evidence concerns the gene SFRP1 and melanoma.